c-Met signaling in lung cancerDate Added: 5/20/2011 9:53:00 AM Last Updated: 5/24/2011 3:18:00 PM
Description of projects available to graduate students: Our laboratory studies hormones and growth factors that control lung cancer growth and survival. This project will examine the hepatocyte growth factor (HGF) and its receptor, c-Met. Downstream effects of c-Met signaling will be measured, including how this receptor tyrosine kinase cross-activates other receptors such as the epidermal growth factor receptor. Use of selective inihibitors of HGF and c-Met to reduce lung cancer growth and survival, alone and in combination with other targeted anti-cancer drugs, will be pursued. Techniques graduate student will learn: immunoblotting, cell culture, ELISA assays, siRNA, animal xenografts, confocal and immunofluorescent microscopy, immunoprecipitation, MTA assay, immunohistochemistry
|
Jill SiegfriedMolecular Pharmacology Cellular And Molecular Pathology Email: siegfriedjm@upmc.edu Return to list
|